Barresi Valeria, Reggiani Bonetti Luca, Ieni Antonio, Domati Federica, Tuccari Giovanni
Department of Human Pathology, University of Messina, Messina 98125, Italy.
Department of Laboratory Integrated Activities, Anatomic Pathology and Legal Medicine, University of Modena and Reggio Emilia, Modena 41124, Italy.
Hum Pathol. 2015 Nov;46(11):1722-9. doi: 10.1016/j.humpath.2015.07.013. Epub 2015 Jul 29.
Mucinous adenocarcinoma (MAC) of the colon and rectum is a histological entity with still indefinite prognostic significance. Although it was previously designated as poorly differentiated by convention, the most recent World Health Organization guidelines indicate that the level of maturation of the epithelium determines differentiation in MAC and that microsatellite instability status should be taken into account for its histological grading. Nonetheless, precise criteria for grading are not provided, and the prognostic value of histological grading in MAC still remains unclear. In the present study we aimed to investigate the prognostic value of a grading system based on the counting of poorly differentiated clusters (PDC) of neoplastic cells in 108 colorectal MACs and to compare its reproducibility and significance with those of a grading system based on glandular differentiation. We found that PDC grade was more reproducible and significantly associated with disease progression (P = .0089) as well as with death from colorectal cancer (P = .0035) in our MACs, as compared to the grade based on glandular differentiation, which was not associated with any of the clinicopathologic variables. Moreover, PDC grade emerged as a significant, independent prognostic factor of recurrence-free survival (P = .0198) and cancer-specific survival (P = .0293) in MAC. Interestingly, the prognostic value of PDC grade was unaltered following incorporation of mismatch repair system status in grading. In conclusion, we demonstrated for the first time that PDC grading is feasible, reproducible, and prognostically relevant in MAC, which may support its use in routine practice.
结肠和直肠黏液腺癌(MAC)是一种组织学实体,其预后意义仍不明确。尽管以前按照惯例将其定为低分化,但世界卫生组织最新指南指出,上皮细胞的成熟程度决定了MAC的分化情况,并且在其组织学分级中应考虑微卫星不稳定性状态。尽管如此,并未提供精确的分级标准,MAC组织学分级的预后价值仍不清楚。在本研究中,我们旨在调查基于108例结直肠MAC中肿瘤细胞低分化簇(PDC)计数的分级系统的预后价值,并将其可重复性和意义与基于腺分化的分级系统进行比较。我们发现,与基于腺分化的分级相比,PDC分级在我们的MAC中更具可重复性,并且与疾病进展(P = 0.0089)以及结直肠癌死亡(P = 0.0035)显著相关,而基于腺分化的分级与任何临床病理变量均无关联。此外,PDC分级是MAC中无复发生存(P = 0.0198)和癌症特异性生存(P = 0.0293)的重要独立预后因素。有趣的是,在分级中纳入错配修复系统状态后,PDC分级的预后价值并未改变。总之,我们首次证明PDC分级在MAC中是可行的、可重复的且具有预后相关性,这可能支持其在常规实践中的应用。